From data lakes to streamlined production, Kriya, Opus, and Epicrispr discuss how technology is improving their operations.
Chimeric antigen receptor (CAR) -T-cell therapies have yielded remarkable results in the treatment of hematological malignancies. Several autologous CAR T-cell products have received marketing ...
Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...
Researchers from the Critical Analytics for Manufacturing Personalized Medicine (CAMP), an interdisciplinary research group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), in ...
Transition from the manual processes that are performed during the initial research and development (R&D) stage to automated processes for later and commercial stage cell therapy manufacturing can be ...
Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...
CDMO and multimodal biosafety testing organization, today announced the enhancement of its dedicated GMP cell banking suites ...
Critical Resources Ltd (ASX:CRR, FRA:9S70) has advanced its solid-state lithium-ion battery evaluation program into ...
Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study Healthy volunteers were recruited and underwent ...